Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-15
1993-07-27
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
052310990
ABSTRACT:
The invention relates to a method of treating psychosis in a mammal which comprises administering to the mammal an effective amount of a dopamine receptor antagonist antipsychotic and a sigma receptor antagonist having greater affinity for sigma receptors than for dopamine receptors, in an amount effective to selectively enhance the antipsychotic effects of the dopamine receptor antagonist relative to the adverse side effects of the dopamine receptor antagonist.
REFERENCES:
patent: 4232037 (1980-11-01), Florvall et al.
patent: 4400383 (1983-08-01), Davidson et al.
patent: 4588728 (1986-05-01), Ferris
Ferris et al., J. Pharm. Pharmacol. 1982, 34:388.
Ferris et al., Life Sciences, 1986, 38:2329.
Ogren et al., Eur. J. Pharm. 1984, 102:439.
Snyder and Largent, J. Neuropsyc. 1989, 1:7.
Taylor and Dekleva, Drug Dev. Res. 1987, 112:65.
Du Pont Merck Pharmaceutical Company
Ferguson Blair Q.
Friedman S. J.
LandOfFree
Use of sigma receptor antagonists to enhance the effects of anti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sigma receptor antagonists to enhance the effects of anti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sigma receptor antagonists to enhance the effects of anti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2342444